keyword
https://read.qxmd.com/read/38637875/pleuroparenchymal-fibroelastosis-as-a-late-complication-of-childhood-cancer-therapy-a-case-series
#21
JOURNAL ARTICLE
Priya H Marathe, Valeria Santibanez, Paul A Meyers, Maria L Padilla, Danielle N Friedman
Pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial pneumonia with distinct clinicopathologic features. It has been associated with exposure to hematopoietic stem cell transplantation (HSCT) and classical alkylating agents. Here, we highlight PPFE as a late complication of childhood cancer therapy by describing the cases of four survivors of childhood cancer with a diagnosis of treatment-related PPFE. All patients received high-dose alkylating agents. PPFE should be considered in the differential diagnosis of restrictive lung disease in patients with history of exposure to alkylating agents or HSCT...
April 18, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38637872/advancements-in-fertility-preservation-strategies-for-pediatric-male-cancer-patients-a-review-of-cryopreservation-and-transplantation-of-immature-testicular-tissue
#22
REVIEW
Zih-Yi Sung, Yong-Qi Liao, Jung-Hsiu Hou, Hong-Hsien Lai, Sung-Ming Weng, Hai-Wei Jao, Buo-Jia Lu, Chi-Huang Chen
Recently, there has been increasing emphasis on the gonadotoxic effects of cancer therapy in prepubertal boys. As advances in oncology treatments continue to enhance survival rates for prepubertal boys, the need for preserving their functional testicular tissue for future reproduction becomes increasingly vital. Therefore, we explore cutting-edge strategies in fertility preservation, focusing on the cryopreservation and transplantation of immature testicular tissue as a promising avenue. The evolution of cryopreservation techniques, from controlled slow freezing to more recent advancements in vitrification, with an assessment of their strengths and limitations was exhibited...
April 18, 2024: Reproductive Biology and Endocrinology: RB&E
https://read.qxmd.com/read/38637871/bilateral-wilms-tumor-with-anaplasia-a-report-from-the-children-s-oncology-group-study-aren0534
#23
JOURNAL ARTICLE
Rodrigo L P Romao, Jennifer H Aldrink, Lindsay A Renfro, Elizabeth A Mullen, Andrew J Murphy, Jack Brzezinski, Marcus M Malek, Daniel J Benedetti, Nicholas G Cost, Ethan Smith, Jeffrey S Dome, Andrew M Davidoff, Amy Treece, Lauren N Parsons, Conrad V Fernandez, Brett Tornwall, Robert C Shamberger, Arnold Paulino, John A Kalapurakal, James I Geller, Peter F Ehrlich
INTRODUCTION: The purpose of this study is to examine the outcomes in children with anaplastic bilateral Wilms tumor (BWT) from study AREN0534 in order to define potential prognostic factors and areas to target in future clinical trials. METHODS: Demographic and clinical data from AREN0534 study patients with anaplasia (focal anaplasia [FA], or diffuse anaplasia [DA]) were compared. Event-free survival (EFS) and overall survival (OS) were reported using Kaplan-Meier estimation with 95% confidence bands, and differences in outcomes between FA and DA compared using log-rank tests...
April 18, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38637852/ikzf1-plus-alterations-contribute-to-outcome-disparities-in-hispanic-latino-children-with-b-lymphoblastic-leukemia
#24
JOURNAL ARTICLE
Alexandra E Kovach, Maximilian Wengyn, My H Vu, Andrew Doan, Gordana Raca, Deepa Bhojwani
BACKGROUND: Compared to other ethnicities, Hispanics/Latinos (H/L) have a high incidence of acute lymphoblastic leukemia (ALL), enrichment of unfavorable ALL genetic subtypes, and worse outcomes, even after correcting for socioeconomic factors. We previously demonstrated increased incidence of the high-risk genetic drivers IKZF1 deletion and IGH::CRLF2 rearrangement in H/L compared to non-H/L children with B-ALL. Here in an expanded pediatric cohort, we sought to identify novel genetic drivers and secondary genetic alterations in B-ALL associated with H/L ethnicity...
April 18, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38637207/central-venous-catheter-consideration-in-pediatric-oncology-a-systematic-review-and-meta-analysis-from-the-american-pediatric-surgical-association-cancer-committee
#25
JOURNAL ARTICLE
Emily R Christison-Lagay, Erin G Brown, Jennifer Bruny, Melissa Funaro, Richard D Glick, Roshni Dasgupta, Christa N Grant, Abigail J Engwall-Gill, Timothy B Lautz, David Rothstein, Ashley Walther, Peter F Ehrlich, Jennifer H Aldrink, David Rodeberg, Reto M Baertschiger
BACKGROUND: Tunneled central venous catheters (CVCs) are the cornerstone of modern oncologic practice. Establishing best practices for catheter management in children with cancer is essential to optimize care, but few guidelines exist to guide placement and management. OBJECTIVES: To address four questions: 1) Does catheter composition influence the incidence of complications; 2) Is there a platelet count below which catheter placement poses an increased risk of complications; 3) Is there an absolute neutrophil count (ANC) below which catheter placement poses an increased risk of complications; and 4) Are there best practices for the management of a central line associated bloodstream infection (CLABSI)? METHODS: Data Sources: English language articles in Ovid Medline, PubMed, Embase, Web of Science, and Cochrane Databases...
March 27, 2024: Journal of Pediatric Surgery
https://read.qxmd.com/read/38633779/incidence-and-survival-of-pediatric-and-adult-hepatocellular-carcinoma-united-states-2001-2020
#26
Azlann Arnett, David A Siegel, Shifan Dai, Trevor D Thompson, Jennifer Foster, Erika J di Pierro, Behnoosh Momin, Philip J Lupo, Andras Heczey
IMPORTANCE: Hepatocellular carcinoma accounts for approximately 80% of liver neoplasms. Globally, hepatocellular carcinoma ranks as the third most lethal cancer, with the number of deaths expected to further increase by 2040. In adults, disparities in incidence and survival are well described while pediatric epidemiology is not well characterized. OBJECTIVE: To describe incidence and survival for pediatric (ages 0-19 years) hepatocellular carcinoma cases and compare these measures to adults (ages ≥20 years) diagnosed with hepatocellular carcinoma...
April 5, 2024: medRxiv
https://read.qxmd.com/read/38632356/mir-124-3p-and-mir-194-5p-regulation-of-the-pi3k-akt-pathway-via-ror2-in-medulloblastoma-progression
#27
JOURNAL ARTICLE
Chen Wang, Runxi Fu, Yunkun Wang, Jia Wei, Ying Yu, Liuhua Hu, Chenran Zhang
Medulloblastoma (MB), a prevalent pediatric central nervous system tumor, is influenced by microRNAs (miRNAs) that impact tumor initiation and progression. However, the specific involvement of miRNAs in MB tumorigenesis remains unclear. Using single-cell RNA sequencing, we identified ROR2 expression in normal human fetal cerebellum. Subsequent analyses, including immunofluorescence, quantitative real-time PCR (qRT-PCR), and Western blot, assessed ROR2 expression in MB tissues and cell lines. We investigated miR-124-3p and miR-194-5p and their regulatory role in ROR2 expression through the dual-luciferase reporter, qRT-PCR, and western blot assays...
March 19, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38629258/off-label-prescribing-of-immune-checkpoint-inhibitor-therapy-at-a-single-pediatric-cancer-center
#28
JOURNAL ARTICLE
Ajami Gikandi, Susan N Chi, Kee Kiat Yeo, Allison F O'Neill, David S Shulman, Steven G DuBois, Natalie B Collins
BACKGROUND: Immune checkpoint inhibitors (ICI) have improved outcomes in a variety of adult cancers and are prescribed with increasing frequency across oncology. However, patterns of off-label use of ICI in pediatrics remain unclear. METHODS: This is a single-institution, retrospective cohort study evaluating off-label ICI use in pediatric and young adult patients with cancer treated at our institution from 2014 to 2022. Response was based on clinician assessment derived from clinical records...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38628594/helical-tomotherapy-craniospinal-irradiation-in-primary-brain-tumours-toxicities-and-outcomes-in-a-peadiatric-and-adult-population
#29
JOURNAL ARTICLE
Julie Savagner, Anne Ducassou, Bastien Cabarrou, Gregory Hangard, Marion Gambart, Anne-Isabelle Bertozzi, Eloise Baudou, Sergio Boetto, Delphine Larrieu, Anne Laprie
OBJECTIVE: As craniospinal irradiation (CSI) is delivered more frequently by helical tomotherapy (HT) with few reports about late effects, we analysed all patients treated in our centre over an 11-year period. METHODS AND MATERIALS: Our study included all patients that underwent CSI by HT, between September 2009 and January 2020, in the Department of Radiation Oncology of the Toulouse Cancer Institute. Acute radiotherapy toxicities were reported and medium- to long-term outcomes analysed...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38627902/extrapleural-pneumonectomy-for-sarcoma-outcomes-of-adult-patients-at-a-specialized-center
#30
JOURNAL ARTICLE
Betty Y Zhang, Ashley R Wilson-Smith, Elizabeth A Connolly, Madeleine C Strach, Nathan Ussher, Tristan Yan, Vivek A Bhadri
BACKGROUND: Extrapleural pneumonectomy (EPP) is a complex surgical procedure involving en-bloc resection of the parietal and visceral pleura, lung, pericardium, and ipsilateral diaphragm. Small case series of pleural-based sarcoma of predominantly pediatric patients suggest EPP may be a life-prolonging surgical option. We aimed to describe the characteristics and outcomes of adults who underwent EPP at a specialized sarcoma center. METHODS: Clinicopathologic variables, surgical details, and follow-up information were extracted for patients undergoing EPP for pleural-based sarcoma between August 2017 and December 2020...
April 2024: Cancer reports
https://read.qxmd.com/read/38627891/discovering-needs-for-palliative-care-in-children-with-cancer-in-indonesia
#31
JOURNAL ARTICLE
Alexandra Widita Swipratami Pangarso, Sri Mulatsih, Mei Neni Sitaresmi, Susanne Verhulst, Gertjan Kaspers, Saskia Mostert
BACKGROUND: Although most children with cancer die in low- and middle-income countries, palliative care receives limited attention in these settings. This study explores parents' perspectives on experiences and needs of children dying from cancer. METHODS: Home visits were conducted to interview parents of children, who were treated for cancer at an Indonesian academic hospital and died between 2019 and 2020, using semi-structured questionnaires. RESULTS: Parents of 49 children (response rate 74%) were interviewed...
April 16, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38627882/event-free-survival-in-relapsed-and-refractory-rhabdomyosarcoma-treated-on-cooperative-group-phase-ii-trials-a-report-from-the-children-s-oncology-group
#32
JOURNAL ARTICLE
Jonathan Metts, Wei Xue, Zhengya Gao, Sapna Oberoi, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
BACKGROUND: Novel therapies are needed for relapsed and refractory rhabdomyosarcoma (RRMS). Phase II clinical trials in RRMS have typically utilized radiologic response as the primary activity endpoint, an approach that poses several limitations in RRMS. In this analysis, we aimed to estimate an event-free survival (EFS) endpoint for RRMS that could be used as a benchmark for future studies. PROCEDURE: We performed a retrospective study of patients with RRMS enrolling on 13 single-agent phase II Children's Oncology Group and legacy group trials from 1997 to 2016...
April 16, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38627747/current-practices-of-craniospinal-irradiation-techniques-in-turkey-a-comprehensive-dosimetric-analysis
#33
JOURNAL ARTICLE
Öznur Şenkesen, Evrim Tezcanlı, Fadime Alkaya, Burçin İspir, Serap Çatlı, Abdullah Yeşil, Ebrar Bezirganoglu, Sezgi Turan, Canan Köksal, Gülay Güray, Emel Hacıislamoğlu, İsmail Faruk Durmuş, Şeyma Çavdar, Telat Aksu, Nurten Çolak, Esra Küçükmorkoç, Mustafa Doğan, Tülay Ercan, Fatih Karaköse, Vildan Alpan, Cemile Ceylan, Gökhan Poyraz, Nilgül Nalbant, Şeyda Kınay, Servet İpek, Namık Kayalılar, Hamza Tatlı, Mingyao Zhu
OBJECTIVE: This study evaluates various craniospinal irradiation (CSI) techniques used in Turkish centers to understand their advantages, disadvantages and overall effectiveness, with a focus on enhancing dose distribution. METHODS: Anonymized CT scans of adult and pediatric patients, alongside target volumes and organ-at-risk (OAR) structures, were shared with 25 local radiotherapy centers. They were tasked to develop optimal treatment plans delivering 36 Gy in 20 fractions with 95% PTV coverage, while minimizing OAR exposure...
April 16, 2024: Radiation Oncology
https://read.qxmd.com/read/38627334/evaluation-of-chemotherapy-induced-nausea-and-vomiting-in-pediatric-patients-with-high-grade-glioma-treated-with-lomustine-a-case-series
#34
JOURNAL ARTICLE
Kim P J Schellekens, Sarah Babette Hageman, Els C Haverkate, Marianne D van de Wetering, Frederike K Engels, Aeltsje Brinksma, Evelien de Vos-Kerkhof
PURPOSE: Although lomustine has been used as a chemotherapeutic agent for decades, no recommendation on appropriate chemotherapy-induced nausea and vomiting (CINV) prophylaxis is available. As CINV is considered one of the most bothersome side effects of chemotherapy, adequate prophylaxis is of relevance to improve quality of life during cancer treatment. The aim of this retrospective case series was to report the incidence and severity of CINV in pediatric patients with high-grade glioma treated with lomustine and to formulate recommendations for appropriate CINV prophylaxis...
April 16, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38627241/adolescents-and-young-adults-aya-with-cancer-the-clinical-course-of-covid-19-infections
#35
JOURNAL ARTICLE
Julie A Wolfson, Elizabeth S Davis, Aniket Saha, Isaac Martinez, David McCall, Prachi Kothari, Julienne Brackett, David S Dickens, Alissa R Kahn, Carla Schwalm, Archana Sharma, Joshua Richman, Branko Cuglievan, Smita Bhatia, Chen Dai, Jennifer M Levine, Emily E Johnston
Adolescents and Young Adults (AYAs: 15-39 y) with cancer face unique vulnerabilities, yet remain under-represented on clinical trials, including adult registries of COVID-19 in cancer (AYAs: 8-12%). Thus, we leveraged the Pediatric Oncology COVID-19 Case Report (POCC) to examine the clinical course of COVID-19 among AYAs with cancer. POCC collects de-identified clinical and sociodemographic data regarding 0-39yo with cancer (AYAs = 37%) and COVID-19 from >100 institutions. Between 04/01/2020-11/28/2023, 191 older AYAs [22-39y] and 640 younger AYAs [15-21y] were captured...
April 16, 2024: Journal of the National Cancer Institute
https://read.qxmd.com/read/38622789/disease-modifying-therapies-for-sickle-cell-disease-decisional-needs-and-supports-among-adolescents-and-young-adults
#36
JOURNAL ARTICLE
Ke Ding, Benjamin Bear, Erica Sood, Melissa Alderfer, Lori Crosby, Aimee K Hildenbrand
BACKGROUND: Shared decision-making is one promising solution to addressing barriers in use of disease-modifying therapies for adolescents and young adults (AYAs) with sickle cell disease (SCD). A thorough understanding of decisional needs can guide the development of decisional supports and promote shared decision-making. PROCEDURE: Informed by the Ottawa Decision Support Framework (ODSF), we conducted a qualitative analysis to assess decisional needs and supports reported by AYAs with SCD, their caregivers, and healthcare providers...
April 15, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38622740/treating-sex-and-gender-differences-as-a-continuous-variable-can-improve-precision-cancer-treatments
#37
JOURNAL ARTICLE
Wei Yang, Joshua B Rubin
BACKGROUND: The significant sex and gender differences that exist in cancer mechanisms, incidence, and survival, have yet to impact clinical practice. One barrier to translation is that cancer phenotypes cannot be segregated into distinct male versus female categories. Instead, within this convenient but contrived dichotomy, male and female cancer phenotypes are highly overlapping and vary between female- and male- skewed extremes. Thus, sex and gender-specific treatments are unrealistic, and our translational goal should be adaptation of treatment to the variable effects of sex and gender on targetable pathways...
April 15, 2024: Biology of Sex Differences
https://read.qxmd.com/read/38622709/impact-of-long-covid-in-children-a-large-cohort-study
#38
JOURNAL ARTICLE
Ziv Hersh, Yiska Loewenberg Weisband, Ariel Bogan, Adir Leibovich, Uri Obolski, Daniel Nevo, Ran Gilad-Bachrach
BACKGROUND: The impact of long-term Coronavirus disease 2019 (COVID-19) on the pediatric population is still not well understood. This study was designed to estimate the magnitude of COVID-19 long-term morbidity 3-6 months after the date of diagnosis. METHODS: A retrospective study of all Clalit Health Services members in Israel aged 1-16 years who tested positive for SARS-CoV-2 between April 1, 2020 and March 31, 2021. Controls, who had no previous diagnosis of COVID-19, were one-to-one matched to 65,548 COVID-19-positive children and teens, and were assigned the infection dates of their matches as their index date...
April 15, 2024: Child and Adolescent Psychiatry and Mental Health
https://read.qxmd.com/read/38621457/circrnas-as-prognostic-markers-in-pediatric-acute-myeloid-leukemia
#39
JOURNAL ARTICLE
Huiying Sun, Yangyang Xie, Xiaoyan Wu, Wenting Hu, Xiaoxiao Chen, Kefei Wu, Han Wang, Shuang Zhao, Qiaoqiao Shi, Xiang Wang, Bowen Cui, Wenyan Wu, Rongrong Fan, Jianan Rao, Ronghua Wang, Ying Wang, Ying Zhong, Hui Yu, Binbing S Zhou, Shuhong Shen, Yu Liu
Circular RNAs (circRNAs) arise from precursor mRNA processing through back-splicing and have been increasingly recognized for their functions in various cancers including acute myeloid leukemia (AML). However, the prognostic implications of circRNA in AML remain unclear. We conducted a comprehensive genome-wide analysis of circRNAs using RNA-seq data in pediatric AML. We revealed a group of circRNAs associated with inferior outcomes, exerting effects on cancer-related pathways. Several of these circRNAs were transcribed directly from genes with established functions in AML, such as circRUNX1, circWHSC1, and circFLT3...
April 13, 2024: Cancer Letters
https://read.qxmd.com/read/38619829/burden-of-childhood-cancer-and-the-social-and-economic-challenges-in-adulthood-a-systematic-review-and-meta-analysis
#40
JOURNAL ARTICLE
Márk Viktor Hernádfoi, Dóra Kornélia Koch, Tamás Kói, Marcell Imrei, Rita Nagy, Vanda Máté, Réka Garai, Jessica Donnet, József Balogh, Gábor T Kovács, Andrea Párniczky, Péter Hegyi, Miklós Garami
IMPORTANCE: Significant advancements in pediatric oncology have led to a continuously growing population of survivors. Although extensive research is being conducted on the short-, medium-, and long-term somatic effects, reports on psychosocial reintegration are often conflicting; therefore, there is an urgent need to synthesize the evidence to obtain the clearest understanding and the most comprehensive answer. OBJECTIVE: To provide a comprehensive review and analysis of the socioeconomic attainment of childhood cancer survivors (CCSs) compared with their unaffected peers...
April 15, 2024: JAMA Pediatrics
keyword
keyword
29772
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.